CPRR Reagents, Controls, and Consumables for Coagulation Testing at NHTP
ID: HT941025Q0041Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Defense, through the Defense Health Agency, is seeking quotes for a supply purchase order contract for cost-per-reportable results (CPPR) reagents, controls, and consumables for coagulation testing at Naval Hospital Twentynine Palms (NHTP) in California. The procurement includes the leasing of two bench-top coagulation analyzers, FDA-approved reagents, and consumables necessary for testing key assays such as PT, INR, aPTT, D-Dimer, and Fibrinogen, which are vital for monitoring patient hemostasis and thrombosis. This initiative aims to enhance healthcare services for U.S. military personnel and their families, ensuring reliable and efficient testing capabilities while adhering to budgetary constraints. Interested vendors must submit their quotes by March 21, 2025, and can direct inquiries to Tracy Robinson at tracy.m.robinson18.civ@health.mil or CHA-ON Gordon at cha-on.p.gordon2.civ@health.mil.

    Point(s) of Contact
    Files
    Title
    Posted
    The government solicitation HT941025Q0041 seeks quotes for coagulation testing supplies and services for Naval Hospital Twentynine Palms (NHTP). The contract includes a firm-fixed-price agreement for cost-per-reportable results (CPPR) reagents, controls, and consumables, along with the provision of analyzers, quality controls, training, and maintenance services. The contract will span six months with four optional one-year extensions. Interested vendors must comply with relevant Federal Acquisition Regulation (FAR) and Defense Federal Acquisition Regulation Supplement (DFARS) clauses and provide all requested documentation. Evaluation of proposals will focus on technical capability, delivery requirements, and price, with delivery being the most heavily weighted factor. Vendors are required to submit quotes by March 21, 2025, and are encouraged to ensure timely submission, as late bids may not be accepted. This solicitation reflects the government's commitment to acquiring essential medical supplies efficiently, emphasizing compliance and quality assurance in the procurement process.
    The Naval Hospital Twentynine Palms (NHTP) in California seeks to procure coagulation testing equipment through a cost-per-reportable-results contract to enhance its healthcare services for U.S. military personnel and families. The contract includes leasing two bench-top coagulation analyzers and providing FDA-approved reagents and consumables for testing key assays such as PT, INR, aPTT, D-Dimer, and Fibrinogen, essential for monitoring patient hemostasis and thrombosis. The selected contractor must offer full-time support during the validation phase, integrate with the MHS Genesis Information System, and ensure minimal maintenance needs. Additional service requirements include annual operator training, emergency support, and detailed labeling for special handling supplies. Deliveries are scheduled across multiple years, with specific dimensions for the analyzers noted for compatibility with existing lab space. The overarching goal is to ensure reliable and efficient testing capabilities within budgetary constraints, ultimately supporting the health of military personnel and their families at NHTP.
    Lifecycle
    Title
    Type
    Similar Opportunities
    6640--Coagulation Follow-on Contract (VA-25-00007795) 589-25-3-1598-0003
    Buyer not available
    The Department of Veterans Affairs is preparing to award a firm fixed price contract for coagulation testing services and supplies across multiple facilities within the VISN 15 network. This procurement aims to cover the cost per reportable result for PT/PTT coagulation equipment and associated testing supplies, with a contract structure that includes a base period and four optional years. The services are critical for ensuring accurate and timely coagulation testing, which is essential for patient care in various medical settings. Interested bidders must be registered and active in the System for Award Management (SAM) to participate, with the solicitation expected to be released electronically on or around March 4, 2025. For further inquiries, potential contractors can contact Contracting Officer Lisa A. Buchanan at lisa.buchanan1@va.gov or by phone at 913-946-1990.
    Blood Coagulation Analyzer and Reagents
    Buyer not available
    The Department of Defense, through the Medical Readiness Contracting Office - East, is seeking qualified contractors to provide a blood coagulation analyzer and associated reagents for the Womack Army Medical Center located in Fort Liberty, North Carolina. The contract will require the contractor to supply all necessary personnel, equipment, maintenance, and training to ensure the effective operation of automated coagulation testing systems, with reagents ordered on an as-needed basis from May 1, 2024, to July 31, 2030. This procurement is critical for maintaining high-quality medical testing solutions in a military healthcare setting, ensuring compliance with federal regulations, including FDA standards. Interested parties should refer to the attached solicitation document for detailed requirements and submission instructions, and may contact Victoria Manigault or Michael J. McCollum for further information.
    Hematology Testing - Cost Per Reportable Result
    Buyer not available
    The Department of Defense, specifically the U.S. Army, is soliciting proposals for an automated hematology analyzer system to be delivered to the U.S. Army Health Clinic in Vicenza, Italy. The contract requires the contractor to provide, install, and maintain the analyzer, along with supplying necessary reagents and materials for hematology testing, with an ordering period from May 1, 2025, to September 30, 2029, and a minimum contract value of $1,000. This procurement is critical for enhancing healthcare capabilities at the clinic, ensuring compliance with federal regulations, including HIPAA, and maintaining patient confidentiality. Interested parties, particularly small businesses, service-disabled veteran-owned, and women-owned enterprises, should contact Elena Raspitha at elena.m.raspitha.civ@health.mil for further details.
    U.S. Naval Hospital Chinhae, South Korea Laboratory Testing Services
    Buyer not available
    The Defense Health Agency (DHA) is soliciting quotes for Laboratory Blood Testing Services at the U.S. Naval Hospital in Chinhae, South Korea, for the fiscal year 2024-2025. The procurement includes a base service and four optional services, with a performance period from October 1, 2024, to September 30, 2025, requiring contractors to provide comprehensive lab blood testing in accordance with the Performance Work Statement. This opportunity is crucial for ensuring timely and accurate medical testing for military personnel, thereby enhancing healthcare services in overseas locations. Interested contractors must submit their quotes electronically by March 21, 2025, and direct any inquiries to Marcela Cervantes at marcela.cervantes.civ@health.mil.
    FY26 One (1) Waterless Integrated Immunochemistry Analyzer and One (1) Waterless Clinical Chemistry Analyzer W/ Cost Per Reportable Result(s) (CPRR)
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking qualified vendors to provide one waterless integrated immunochemistry analyzer and one waterless clinical chemistry analyzer, along with a cost per reportable result (CPRR) model, for the General Leonard Wood Army Community Hospital in Fort Leonard Wood, Missouri. The procurement aims to enhance laboratory capabilities by supplying advanced analyzers that require no water access, ensuring operational efficiency in a dry system environment, and includes comprehensive support such as reagents, maintenance, and training at no additional cost to the government. This initiative reflects a commitment to improving healthcare quality through advanced laboratory technology, with an anticipated contract period from October 1, 2025, to September 30, 2030. Interested parties must submit a Statement of Capability by March 17, 2024, to Joshua Barbero at joshua.p.barbero.civ@health.mil, and must be registered in the System for Award Management (SAM) to be eligible for contract award.
    Hematology Analyzer Leasing
    Buyer not available
    The Department of Defense, specifically the Department of the Air Force, is seeking quotations for the leasing of Hematology Analyzers at Holloman Air Force Base in New Mexico. The procurement requires vendors to provide detailed service documentation and ensure compliance with a comprehensive Statement of Work (SOW), which includes installation, maintenance, and operational requirements for the analyzers, emphasizing accuracy and regulatory compliance. This opportunity is critical for maintaining high-quality healthcare services within military facilities, with a small business size standard of $41.5 million under NAICS code 621511. Interested vendors must submit their proposals via email by 12:00 PM Mountain Time on March 28, 2025, and direct any questions to SSgt Erick Vasquez at erick.vasquez@us.af.mil or Callie M. Spencer at callie.spencer.1@us.af.mil by March 18, 2025.
    FY26 One (1) Waterless Integrated Immunochemistry Analyzer and One (1) Waterless Clinical Chemistry Analyzer W/ Cost Per Reportable Result(s) (CPRR)
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking qualified vendors to provide one waterless integrated immunochemistry analyzer and one waterless clinical chemistry analyzer, along with a cost per reportable result (CPRR) for the General Leonard Wood Army Community Hospital in Fort Leonard Wood, Missouri. This procurement aims to enhance laboratory capabilities by supplying advanced diagnostic equipment that operates without water, ensuring functionality in a designated area without water access, and includes comprehensive support services such as training, reagents, and maintenance. The contract is anticipated to be a five-year Indefinite Delivery Indefinite Quantity (IDIQ) with a proposed delivery period from October 1, 2025, to September 30, 2030. Interested parties must submit a Statement of Capability by March 17, 2024, and direct inquiries to Joshua Barbero at joshua.p.barbero.civ@health.mil.
    6640--554 Chemistry and Immunochemistry CPRR
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 19, is seeking suppliers for Chemistry and Immunochemistry Cost Per Reportable Result (CPRR) services at the Rocky Mountain Regional VA Medical Center in Aurora, Colorado. This sources sought notice aims to gather market information to assess procurement methods and potential small business set-asides, inviting interested vendors to submit capability statements that detail their resources and ability to provide necessary services, including equipment, maintenance, software, training, and supplies for chemistry and immunochemistry testing. These services are crucial for supporting the healthcare needs of veterans, ensuring they receive accurate and timely laboratory results. Responses are due by March 14, 2025, at 2 PM Mountain Time, and interested parties can contact Contracting Officer Edward Emerson at Edward.Emerson@va.gov or by phone at 303-712-5720 for further information.
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    Lab Chemistry Analyzer and Cost-Per-Test Agreement for Robins Air Force Base
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking a sole source contract for a VITROS ® XT 3400 Chemistry Analyzer and a Cost-Per-Test Agreement for the 78th Medical Group Laboratory at Robins Air Force Base in Georgia. The procurement aims to provide a comprehensive laboratory solution that includes the analyzer, reagents, calibrators, controls, and preventive maintenance, all compliant with the Military Health System (MHS) GENESIS electronic health record system. This equipment is crucial for enhancing laboratory analysis capabilities, ensuring efficient and accurate diagnostic testing in support of healthcare services. Interested vendors must submit a Capabilities Statement by 10:00 AM EST on March 24, 2025, to the primary contact, Brittany Belsches, at brittany.n.belsches.civ@health.mil, or Lenore Y. Paseda at lenore.y.paseda.civ@health.mil.